UNeMed Corporation
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha, managing invention disclosures, IP, licensing, and startup formation for university innovators and licensee companies.
- Company typePrivate
- Founded1991
- HeadquartersOmaha, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What UNeMed Corporation does
UNeMed Corporation is the officially designated technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). Founded in 1991 and headquartered in Omaha, Nebraska, the organization processes approximately 100 new invention disclosures annually from university faculty, staff, and students, manages intellectual property (including a portfolio of medical devices, therapeutics, diagnostics, drug-delivery platforms, research tools, and software), executes confidentiality and material-transfer agreements, runs patent prosecution, and structures licensing deals and startup formations. Its primary "customer" on the supply side is the internal UNMC/UNO research community, served free of charge, while its commercial counterparties are licensees and equity-held spinouts such as Goldenrod Therapeutics, Carecubes, Precision Syringe, Docology, RespirAI, and NeuralRegen.
The underlying "technology" UNeMed manages spans the full UNMC and UNO research output, including novel molecules (PDE4B selective inhibitors), automated medical devices (Automated REBOA, Cardiac Vascular Access Graft, Boedeker Suction Catheter), biologics platforms (Parkinson's vaccine, nanogels, nanoformulations for HIV), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), prosthetics, biosensors (DLP 3D-printed wearable hydrogels), and cuffless wearable blood-pressure monitoring. UNeMed does not develop these innovations itself; it provides the institutional machinery — invention intake, IP protection, licensing frameworks, and equity structuring — to bring them to market.
UNeMed generates revenue primarily through licensing royalties (upfront fees, milestone payments, and ongoing royalties from commercialization), equity stakes in spin-out companies, and modest fees from confidentiality and material-transfer agreements. A small online store sells branded merchandise (tech-transfer maps, t-shirts, tumblers) at unit prices ranging from $12.95 to $240. Go-to-market is sales-led and community-led: direct engagement with faculty, recurring events (Idea Pub: Morning Edition, Innovations & Libations, Startup Showcase), the 16-week Steel Works Health Accelerator co-developed with UNeTech Institute and CQuence Health, the annual Innovation Week with Innovation Awards and Demo Day, the Back-o-the-Napkin Contest, and ecosystem partnerships with NMotion/gener8tor, the Greater Omaha Chamber, the Nebraska Department of Economic Development, the U.S. Small Business Administration, and regional investors such as MOVE Venture Capital. UNeMed is co-located with UNeTech at the Catalyst building in Omaha's EDGE District and runs an exclusive "Innovation by Nebraska" co-branding program that allows licensed companies to display the UNMC shield or UNO "O" mark.
UNeMed Corporation firmographics
Firmographics- Name
- UNeMed Corporation
- Legal name
- UNeMed Corporation
- Website
- https://unemed.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha, managing invention disclosures, IP, licensing, and startup formation for university innovators and licensee companies.
- Ownership category
- akta.pro rank
Where UNeMed Corporation is headquartered
LocationHeadquarters
- HQ city
- Omaha
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
UNeMed Corporation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Technology Licensing Royalties: UNeMed generates revenue by licensing UNMC and UNO technologies to companies. Licensing deals may include upfront fees, milestone payments, and ongoing royalties from commercialization of licensed technologies.
- Startup Equity/Stake in Spun-out Companies: UNeMed forms startup companies around university innovations and may take equity stakes in these spinouts as part of the commercialization arrangement, with the Startup Wall celebrating companies that represent over $200 million in investments.
- Confidentiality and Material Transfer Agreement Fees: Fees from executing confidentiality agreements (CDA/NDA) and material transfer agreements (MTA) as part of the technology transfer process.
- Merchandise Sales: UNeMed operates an online store selling branded merchandise including tech transfer maps, annual reports, t-shirts, tumblers, journals, and sport bottles. Price range for map: $30–$240; t-shirts: $18–$20; tumblers: $12.95; journals: $12.95; sport bottles: $20.00.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Core tech transfer services (invention disclosure, IP management, licensing) for university innovators |
| Unit Pricing | Pay-as-you-go | Tech transfer map (printed, custom-framed) |
| Freemium | Annual | Technology Transfer Boot Camp |
| Unit Pricing | Pay-as-you-go | Annual reports (printed) |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels11 records
UNeMed Corporation product offering
Product offeringCore offering
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). It processes approximately 100 invention disclosures per year, manages intellectual property (patents, copyrights), executes confidentiality and material transfer agreements, licenses university-developed technologies to industry, and forms startup companies around those innovations. Its portfolio spans medical devices, therapeutics, diagnostics, drug delivery platforms, research tools, and software, supported by accelerator programs (Steel Works Health Accelerator) and community events (Idea Pub, Innovation Week).
Product overview
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and University of Nebraska at Omaha. The company offers a portfolio of services including technology licensing, startup formation, IP management, and innovation programs. Their technology portfolio includes medical devices (sympathetic vasomotion monitoring, portable laparoscope, cardiac vascular access graft, Boedeker suction catheter, automated REBOA device), therapeutics (osteotropic hydrogel, wearable hydrogels, vaccine strategy for Parkinson's disease), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), software platforms, and prosthetics. UNeMed also runs accelerator programs (Steel Works Health Accelerator) and networking events (Idea Pub: Morning Edition, Innovation Week) to support university innovators and startups.
Differentiator
Problem solved
Functional benefit
Products and services
- Technology Licensing Services End-to-end licensing service for UNMC and UNO innovations, including IP protection, patent prosecution, license negotiation, royalty collection, and compliance management. For university inventors and external companies seeking to commercialize university-developed technologies.
- Startup Formation Services Service for creating new startup companies built around licensed university technologies, including entity formation, equity structuring, founder matching, investor introductions, and operational handoff to UNeTech Institute. For university researchers and external entrepreneurs.
- Invention Disclosure Processing Service for university researchers to formally disclose inventions to UNeMed, triggering evaluation, IP protection decisions, and commercialization pathway selection. Processes approximately 100 disclosures per year from UNMC and UNO.
- Confidentiality and Material Transfer Agreement Services Administrative services for executing Confidentiality Disclosure Agreements (CDA/NDA) and Material Transfer Agreements (MTA) to protect proprietary information and govern exchange of research materials between UNMC/UNO researchers and external partners.
- Steel Works Health Accelerator A 16-week accelerator program that helps early-stage medtech and healthtech startups develop investment-ready companies through structured mentorship, training, and investor preparation. Inaugural cohort of 6 companies graduated June 10, 2026. For pre-seed and seed-stage health tech and medtech startups.
- Boedeker Suction Catheter (Licensed Technology) Airway management device for trauma patients undergoing intubation, invented by Ben Boedeker, MD, PhD. Winner of 2015 EMS World Innovation Award. Customizable tip fits any laryngoscope blade with continuous/intermittent suction or oxygen insufflation. Produced by Truer Medical and distributed via Karl Storz.
- Cardiac Vascular Access Graft (Licensed Technology) Pediatric medical device for correcting heart defects, used in final stages of Fontan procedures. Replaces traditional tubes with permeable membranes to help cardiologists regulate pressure, featuring a radio-opaque ring for radiography.
- Automated REBOA Device (Licensed Technology) Automated hemorrhage control system for resuscitative endovascular balloon occlusion of the aorta. Reduces deaths from catastrophic internal bleeding by maintaining blood supply to vital organs while bypassing damaged areas.
- Cuffless Blood Pressure Monitoring System (Licensed Technology) Cuffless blood pressure monitoring system for wearable devices using pulse wave velocity measurement. Resistant to error, compatible with any device measuring ECG and PPG signals, allowing individuals to acquire high-quality measurements with minimal training.
- Parkinson's Disease Vaccine (Licensed Technology) Therapeutic vaccine combining nitrated alpha-synuclein (N-α-Syn) with vasoactive intestinal peptide (VIP) adjuvant. Elicits adaptive immune response preventing neuronal damage, demonstrating 91 percent survival rate of dopaminergic neurons in preclinical studies.
- MedLens Smartphone Diagnostic Attachment (Licensed Technology)
Quantifiable outcome
- Processes approximately 100 new inventions per year from UNMC and UNO researchers
- +4 more outcomes
Companies that use UNeMed Corporation
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
UNeMed Corporation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
UNeMed Corporation partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered notable, minor, core and major.
- DocologynotableDocology is a Nebraska healthcare startup with AI-powered EMR automation technology. Presented at Idea Pub: Morning Edition; recently closed a successful seed round and kicked off a pilot program for its software package.
- Arbor BankminorArbor Bank provides complimentary refreshments at Idea Pub: Morning Edition events, serving as a co-sponsor of the networking series.
- Goldenrod TherapeuticscoreGoldenrod Therapeutics was established by UNeMed in 2023 to develop the 11h PDE4B inhibitor molecule created by UNMC chemist Corey Hopkins, PhD. UNeMed created the licensing framework and continues to support the company's development. Goldenrod raised a $6.5M seed round led by Ataxia Ventures and an affiliate of Fannin Partners.
- UNeTech InstitutecoreUNeTech Institute is the University of Nebraska's startup incubator supporting entrepreneurial efforts built on university innovations. UNeMed and UNeTech share office space in the Catalyst building, deepening coordination on startup pipeline — UNeMed handles IP and company formation, UNeTech provides operational support (commercial thesis refinement, early customers, operator recruitment, investor meetings).
- Open Range & Techstars OmahanotableOpen Range and Techstars Omaha hosted Startup Weekend at Catalyst Omaha (June 5-7), encouraging 'startup-curious' university faculty, staff, and students to participate. UNeMed promoted the event to its innovator community.
- NMotion powered by gener8tormajorNMotion (powered by gener8tor) organized the Gr8er Plains Summit in collaboration with UNeMed, Greater Omaha Chamber, Nebraska Dept. of Economic Development, and UNeTech. The summit aims to attract active startup investors to Midwest VC-backed startups, coinciding with the Berkshire Hathaway Annual Shareholders Meeting. International delegations from Israel and Canada will attend.
- Greater Omaha ChambermajorThe Greater Omaha Chamber co-organized the Gr8er Plains Summit with UNeMed and other partners, aimed at building a deeper investor bench for Nebraska startups.
- Nebraska Department of Economic DevelopmentmajorNebraska Dept. of Economic Development co-organized the Gr8er Plains Summit to attract investment capital to the state and build follow-on capital for Nebraska startups.
- Catalyst Omaha (EDGE District)coreCatalyst Omaha is a innovation hub in the EDGE District where UNeMed and UNeTech are co-located. The Forge Event Hall within Catalyst hosts UNeMed's Idea Pub: Morning Edition events, Steel Works Health Accelerator programming, and other entrepreneurial events. Co-sponsors Morning Edition and provides free facility tours.
- Precision SyringenotablePrecision Syringe was founded on an innovation created by former UNMC pediatric ophthalmologist Danny Suh, MD — a precision syringe for delicate eye injections. CEO Adrian Blake presented at Idea Pub: Morning Edition; company is preparing for FDA submission and Series A financing.
- Carecubes (UNMC spinoff)notableCarecubes is a medtech startup that developed its FDA-cleared ISTARI product in collaboration with the University of Nebraska Medical Center. UNeMed facilitated the technology transfer that enabled Carecubes' development, and the company recently closed a $6.5M Series A round led by Schooner Capital, Lifeforce Capital, and CQuence Health.
- NeuralRegennotableNeuralRegen is a startup developing colostrum-based neuroprotective therapies for Alzheimer's and Parkinson's diseases, co-founded by Howard Gendelman, MD, Chair of UNMC's Department of Pharmacology and Experimental Neuroscience. UNeMed facilitated the technology transfer. The company partnered with Oehlerking Dairy Farm in Elmwood, Nebraska for colostrum supply.
- Oehlerking Dairy FarmminorOehlerking Dairy Farm in Elmwood, Nebraska provides the colostrum (first milk) needed by NeuralRegen to develop its nutrient-dense neuroprotective therapies.
- University of Nebraska SystemcoreThe University of Nebraska System partnered with CQuence Health, UNeMed, and UNeTech Institute to launch the Steel Works Health Accelerator — a 16-week program supporting early-stage health tech startups. The pilot was funded by a $75,000 SBA grant. UNeMed provides technology transfer and startup formation expertise; UNeTech provides operational startup support.
- CQuence HealthcoreCQuence Health is a local venture organization focused on healthcare-related startups. Partnered with UNeMed and UNeTech to design and co-sponsor the Steel Works Health Accelerator. CEO Kyle Salem expressed vision for Omaha to become the next U.S. biomedical hub.
- UNMC Great Plains IDeA-CTRminorUNMC Great Plains IDeA-CTR co-sponsored the Back-o-the-Napkin Contest with UNeMed, which awarded its 2026 prize to a cross-campus retinal disease monitoring platform collaboration.
- SuhHermsen.comminorThe ergonomic surgical loupe head strap invented by Dr. Donny Suh (former UNMC pediatric ophthalmologist) and James Hermsen is available for purchase at SuhHermsen.com, managed by UNeMed for licensing discussions.
- Truer MedicalnotableTruer Medical produces the Boedeker Suction Catheter, invented by Dr. Ben Boedeker at UNMC and managed by UNeMed. The device won a 2015 EMS World Innovation Award.
- Karl StorznotableKarl Storz distributes a version of the Boedeker Suction Catheter. The catheter is a single-use, disposable device with customizable tip for attaching to any laryngoscope blade, featuring continuous/intermittent suction or oxygen insufflation.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
UNeMed Corporation competitors and assessment
Company assessmentDirect peers
- Wisconsin Alumni Research Foundation (WARF): One of the oldest university technology transfer organizations in the U.S., managing patents and licensing for University of Wisconsin–Madison discoveries. Comparable in its biotech/medtech focus and equity stake strategy in spinouts.
- Stanford Office of Technology Licensing (OTL): Stanford's OTL handles all invention disclosures, patent prosecution, and licensing for Stanford University innovations. Direct functional peer for university IP commercialization.
- Johns Hopkins Technology Ventures: Technology transfer office for Johns Hopkins University, one of the largest academic medical centers in the U.S. Directly comparable in mandate: licensing IP, forming startups, and running commercialization programs from biomedical research output.
- MIT Technology Licensing Office: MIT's centralized tech transfer office handling invention disclosures, patenting, licensing, and startup formation. Directly comparable mission and structure to UNeMed's operations at UNMC/UNO.
- Case Western Reserve University Technology Transfer Office: Tech transfer office at Case Western Reserve University handling IP protection, licensing, and startup creation. Comparable biomedical-heavy portfolio with similar operating scale.
- Washington University in St. Louis - Office of Technology Management: Tech transfer office for Washington University in St. Louis, a leading biomedical research institution. Operates a directly analogous model of licensing and startup formation around academic medical research output.
- Emory University Office of Technology Transfer: Emory's TTO commercializes inventions from Emory's medical and health sciences research. Direct functional peer in licensing biomedical IP and supporting university spinouts.
- University of Michigan Innovation Partnerships: University of Michigan's tech transfer and commercialization arm. Comparable operating model: licensing inventions, forming startups, and accelerating health-tech ventures from a large research portfolio.
Regional players
- University of Minnesota Technology Commercialization: University of Minnesota's tech transfer office in the upper Midwest. Comparable in geographic proximity and biomedical research mix, with a broader portfolio and more resources than UNeMed.
- University of Iowa Research Foundation (UIRF): Regional Midwestern university tech transfer organization, comparable in geography and similar mid-sized biomedical research base. Lighter operating footprint and similar ecosystem positioning to UNeMed.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
UNeMed Corporation social profiles
Digital presenceUNeMed Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
UNeMed Corporation leadership team
Management profileNumber of profiles
Profiles6 records
UNeMed Corporation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UNeMed Corporation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UNeMed Corporation
What does UNeMed Corporation do?
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). It processes approximately 100 invention disclosures per year, manages intellectual property (patents, copyrights), executes confidentiality and material transfer agreements, licenses university-developed technologies to industry, and forms startup companies around those innovations. Its portfolio spans medical devices, therapeutics, diagnostics, drug delivery platforms, research tools, and software, supported by accelerator programs (Steel Works Health Accelerator) and community events (Idea Pub, Innovation Week).
Is UNeMed Corporation a public or private company?
UNeMed Corporation is a private company. It is classified as state government owned and is currently operating.
When was UNeMed Corporation founded?
UNeMed Corporation was founded in 1991. It employs 11 to 50 people.
Where is UNeMed Corporation based?
UNeMed Corporation is headquartered in Omaha, United States, in the North America region.
How does UNeMed Corporation make money?
Four revenue lines are on record. Technology Licensing Royalties are the primary driver. The others are startup Equity/Stake in Spun-out Companies, confidentiality and Material Transfer Agreement Fees and merchandise Sales.
Who are UNeMed Corporation's main competitors?
Direct peers on record are Wisconsin Alumni Research Foundation (WARF), Stanford Office of Technology Licensing (OTL), Johns Hopkins Technology Ventures, MIT Technology Licensing Office, Case Western Reserve University Technology Transfer Office, Washington University in St. Louis - Office of Technology Management, Emory University Office of Technology Transfer and University of Michigan Innovation Partnerships. Regional players are University of Minnesota Technology Commercialization and University of Iowa Research Foundation (UIRF).
Does UNeMed Corporation have an API?
No public API is recorded for UNeMed Corporation.